Antonella Mazzei
Bristol-Myers Squibb (United States)(US)Bristol-Myers Squibb (Sweden)(SE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Melanoma and MAPK Pathways, Radiation Dose and Imaging, Global Cancer Incidence and Screening
Most-Cited Works
- → Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study(2001)168 cited
- → On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study(2015)122 cited
- → The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods(2015)122 cited
- → Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5(2017)100 cited
- → Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5(2015)89 cited
- → Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study(2015)79 cited